Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

SocialDiabetes

Financiado

Hack your Diabetes Experience

The direct annual cost of diabetes is more than €736 billion, with 15% accounting for antidiabetic drugs, 24% for other pharmaceutical compounds and 61% for primary care and hospitalisations. But the social impact is also huge, wi... ver más

30/06/2019

SOCIALDIABETES SL

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

SOCIALDIABETES SL Desarrollo y explotacion de aplicaciones informaticas para dispositivos tecnologicos

TRL 5-6 | 100K€

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-06-30

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

SMEInst-06-2016-2017: Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well

I+D

Cerrada hace 8 años

0% 70% 100%

1 Participantes

SOCIALDIABETES SL

1.62M€ | Lider

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 24 meses Fecha Inicio: 2017-06-30
Fecha Fin: 2019-06-30

Líder del proyecto

SOCIALDIABETES SL

TRL 5-6 | 100K€

Presupuesto del proyecto 2M€

Descripción del proyecto The direct annual cost of diabetes is more than €736 billion, with 15% accounting for antidiabetic drugs, 24% for other pharmaceutical compounds and 61% for primary care and hospitalisations. But the social impact is also huge, with 51% of patients experimenting emotional anxiety, 17% having depression episodes and 19% feeling discriminated because of the condition. Control of glucose in blood (combining diet, physical activity and medication if necessary), control of blood pressure and lipids, and regular screening for damage to the eyes, kidneys and feet, are cost-effective interventions in diabetes management. 1% reduction of HbA1c levels reduces heart attacks by 14%, microvascular complications by 37% and diabetes-related deaths by 21%. SocialDiabetes is a mHealth solution that can reduce HbA1c levels to normal values (6.4%) in 6 months of continuous use. It is based in a set of proprietary algorithms integrated in a mobile application and a web platform where patients can log data (glucose measurements, food intake, insulin administration, exercise) and doctors can monitor the disease. The app also calculates insulin doses, which is a unique feature compared to similar apps, and offers integration with glucose meters from major providers. Currently the solution is being exploited through a B2C model, with a free and a premium subscription plans. The aim of the project is to implement a B2B model catching the attention of major healthcare providers and stakeholders (public and private hospitals, governments, insurers) so they would adopt SocialDiabetes as the standard tool for disease management. The business opportunity lies in the benefits for the health of patients and ultimately in the reduction of costs for the whole system. Product and business development strategic plans have been designed accordingly.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores